Search Results for 'placebo hiv'

placebo hiv published presentations and documents on DocSlides.

TDF-FTC versus Placebo as HIV PrEP for Transgender Women
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
HIV Prevention England Conference
HIV Prevention England Conference
by felicity
18 February 2020. -. A two-stage randomised phase ...
The Bangkok Tenofovir Study
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
Safety and Antiviral Activity Over
Safety and Antiviral Activity Over
by bety
10 Days Following a Single Dose of Subcutaneous GS...
CROI 2015: HIV Prevention Updates
CROI 2015: HIV Prevention Updates
by pamella-moone
Ruanne V Barnabas, . MBChB. . Dphil. Global Heal...
Pre-exposure Prophylaxis for HIV Prevention
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Progress in the HIV Vaccine Field
Progress in the HIV Vaccine Field
by eatsui
Larry Corey, MD. Principal Investigator, NIAID sup...
ART for Prevention… What Happens Next?
ART for Prevention… What Happens Next?
by briana-ranney
Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...
A Vaginal Ring Containing
A Vaginal Ring Containing
by gelbero
Dapivirine. for HIV-1 PrEP. . Ring. A Vaginal Ri...
Towards ending  the AIDS Epidemic:  Progress and Evidence
Towards ending the AIDS Epidemic: Progress and Evidence
by shoulderheinz
Willard . Tinago. , . PhD. HIV . Molecular Researc...
What’s Next – and When:
What’s Next – and When:
by sherrill-nordquist
An Update on Injectable . P. revention. Alex R Ri...
Michael S.  Saag , MD  Eric S.
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
Eric S.  Daar , MD Professor of Medicine
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
Long Acting Injectable Agents for HIV Prevention
Long Acting Injectable Agents for HIV Prevention
by giovanna-bartolotta
Nyaradzo M Mgodi (. MBChB. , . MMed. ). On behalf...
ART as prevention: PEP &
ART as prevention: PEP &
by phoebe-click
PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...
Statistical Design and Analysis for Immune Correlates Asses
Statistical Design and Analysis for Immune Correlates Asses
by myesha-ticknor
Basic Concepts and RV144 Illustration. Yunda Huan...
 Application of the Data:
Application of the Data:
by giovanna-bartolotta
Cardiometabolic Disease Is an Epidemic. Clinical ...
Innovations in HIV Prevention Research
Innovations in HIV Prevention Research
by numeroenergy
:. Novel adherence and diagnostic technologies. Cr...
HVTN 702  Confidential – Do Not Distribute
HVTN 702 Confidential – Do Not Distribute
by quinn
HVTN 702 Protocol Team. Confidential – Do Not Di...
Safety and acceptability trial of the dapivirine vaginal ring in U.S. adolescents
Safety and acceptability trial of the dapivirine vaginal ring in U.S. adolescents
by ximena
K. Bunge. , L. Levy, D. Szydlo, J. Zhang, A. Gaur,...
Long-acting Capsid Inhibitor Effective as
Long-acting Capsid Inhibitor Effective as
by CottonTails
PrEP. Against Vaginal SHIV Transmission in Macaqu...
Lynn Morris  Deputy Vice-Chancellor, Research and
Lynn Morris Deputy Vice-Chancellor, Research and
by helene
Innovation. University of the Witwatersrand, Johan...
PROUD: Results and participant experiences
PROUD: Results and participant experiences
by catherine
Presented by . Mitzy. . Gafos. , behalf of the P...
“Weighing” in on GLP-1 Receptor Agonists
“Weighing” in on GLP-1 Receptor Agonists
by priscilla
for People With HIV. Suman Srinivasa, MD, MS. Mass...